Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study
- 1 February 2019
- journal article
- research article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 57 (2) , 259-266
Abstract
No abstract availableKeywords
Funding Information
- Veterans Affairs Research and Development
- National Institutes of Health (HL30946)
- National Center for Advancing Translational Sciences (RR025014)
This publication has 35 references indexed in Scilit:
- Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypassJournal of Vascular Surgery, 2013
- Reprinted Article “Pathophysiology of Vein Graft Failure: A Review”European Journal of Vascular and Endovascular Surgery, 2011
- Mechanisms for the anti-inflammatory effects of statinsCurrent Opinion in Lipidology, 2011
- Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate ImmunityCirculation Research, 2011
- Natural Antibodies against Phosphorylcholine in Cardiovascular DiseaseAnnals of the New York Academy of Sciences, 2009
- Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern SwedenEuropean Journal of Preventive Cardiology, 2009
- Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humansJournal of Clinical Investigation, 2009
- Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null miceAtherosclerosis, 2006
- Inflammation and AtherosclerosisEuropean Journal of Vascular and Endovascular Surgery, 2006
- Influence of vein size (diameter) on infrapopliteal reversed vein graft patencyJournal of Vascular Surgery, 1990